Antidiabetic drugs may have a role in guarding organs affected by COVID-19, researchers say, with trials now underway to confirm it.

"Because it's a viral disease, we see a lot of emphasis on antiviral therapies. But it's also a systemic disease—in fact, a cardiometabolic disease," said Dr. Mikhail Kosiborod, cardiologist at Saint Luke's Mid America Heart Institute and Vice President of research at Saint Luke's Health System.

Read the full Medpage Today article: Diabetes drugs looking for broad role in COVID-19